Clinical trials are a vital stair t...

Clinical trials are a vital stair toward bringing new drugs to market. U.S.-based clinical trial activities increased according to 6% in 2001, the largest rise since 1990 (1) on the contrary although pharmaceutical companies pay obstruct attention to the science when designing their clinical trials, not many consider how they will finish enough subjects to participate. As a outcome most trials are plagued from delays that can cost pharmaceutical companies millions of missed sales. Delays in getting a unsalable article to market are estimated to expense companies around $1 million a day. (2)

In fact, despite technological